Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

Archana Anantharaman(UCSF Helen Diller Family Comprehensive Cancer Center), Pamela L. Paris(UCSF Helen Diller Family Comprehensive Cancer Center)
BMC Cancer
September 21, 2016
Cited by 105


Related Papers